CATALOGO DEI PRODOTTI DELLA RICERCA

TECCHIO, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.612
NA - Nord America 6.176
AS - Asia 4.099
SA - Sud America 605
AF - Africa 68
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 9
Totale 17.579
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.076
RU - Federazione Russa 2.532
SG - Singapore 1.554
GB - Regno Unito 1.413
CN - Cina 1.388
IT - Italia 560
DE - Germania 511
BR - Brasile 503
SE - Svezia 379
HK - Hong Kong 368
FR - Francia 347
IE - Irlanda 297
VN - Vietnam 284
FI - Finlandia 256
JP - Giappone 114
KR - Corea 96
UA - Ucraina 82
IN - India 65
CA - Canada 64
ES - Italia 49
AR - Argentina 43
ID - Indonesia 41
TR - Turchia 39
BE - Belgio 34
PL - Polonia 34
NL - Olanda 33
AT - Austria 28
BD - Bangladesh 26
IQ - Iraq 26
ZA - Sudafrica 25
MX - Messico 24
IR - Iran 19
PK - Pakistan 13
VE - Venezuela 13
CO - Colombia 10
EC - Ecuador 10
CH - Svizzera 9
MA - Marocco 9
UZ - Uzbekistan 9
BJ - Benin 8
KE - Kenya 8
LT - Lituania 8
PY - Paraguay 8
AU - Australia 7
IL - Israele 7
JO - Giordania 7
AZ - Azerbaigian 6
CL - Cile 6
PE - Perù 6
CZ - Repubblica Ceca 5
DK - Danimarca 5
MY - Malesia 5
NP - Nepal 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AE - Emirati Arabi Uniti 4
EU - Europa 4
RO - Romania 4
TG - Togo 4
TN - Tunisia 4
BG - Bulgaria 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
NO - Norvegia 3
OM - Oman 3
PT - Portogallo 3
UY - Uruguay 3
AL - Albania 2
BB - Barbados 2
BY - Bielorussia 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
GY - Guiana 2
HN - Honduras 2
JM - Giamaica 2
KW - Kuwait 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
MZ - Mozambico 2
NZ - Nuova Zelanda 2
PA - Panama 2
TH - Thailandia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
GA - Gabon 1
GI - Gibilterra 1
GR - Grecia 1
GT - Guatemala 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
ME - Montenegro 1
Totale 17.570
Salva come PNG Salva come JPEG
Città #
Southend 1.228
Dallas 1.015
Moscow 882
Singapore 743
Chandler 705
Ashburn 688
Jacksonville 577
Woodbridge 391
Hong Kong 364
Ann Arbor 327
Dublin 292
Beijing 246
Houston 209
Verona 197
New York 125
Wilmington 114
Jinan 112
Lawrence 108
Princeton 108
The Dalles 106
Los Angeles 97
Munich 97
Ho Chi Minh City 88
Nanjing 86
Shenyang 81
Hebei 69
Milan 61
Buffalo 56
Turku 53
São Paulo 51
Tianjin 50
Changsha 48
Hanoi 46
Tokyo 45
Helsinki 44
Redondo Beach 43
Sindelfingen 41
Columbus 37
Nanchang 36
Boardman 35
Santa Clara 34
Brussels 33
Dong Ket 33
Guangzhou 32
Ningbo 32
Taizhou 32
Zhengzhou 32
Haikou 30
Taiyuan 30
Jakarta 29
Seattle 29
Hangzhou 27
London 26
Stockholm 26
Warsaw 26
Bologna 24
Jiaxing 24
Madrid 24
Council Bluffs 23
Dearborn 23
Redmond 23
San Francisco 23
Seoul 23
Brooklyn 22
Chicago 22
Frankfurt am Main 22
Chennai 21
Kent 21
Montreal 21
Fuzhou 20
Lappeenranta 20
Belo Horizonte 19
Denver 19
Johannesburg 19
Norwalk 18
Lanzhou 17
Düsseldorf 16
Nuremberg 16
Redwood City 16
Shanghai 16
Toronto 16
Nürnberg 15
Orem 15
Phoenix 15
Rome 15
San Giovanni Lupatoto 15
Vienna 15
Haiphong 14
Lancaster 14
Poplar 14
Fairfield 13
Rio de Janeiro 13
Brasília 12
San Jose 12
Ankara 11
Manchester 11
Hải Dương 10
Atlanta 9
Baghdad 9
Boston 9
Totale 10.921
Salva come PNG Salva come JPEG
Nome #
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 428
Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation 418
Acute lymphoblastic leukemia (ALL) in elderly patients receiving intensive treatment. Experience in 26 consecutive patients 247
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 234
A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients 234
CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors 221
NEUROLOGICAL COMPLICATIONS IN ADULT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS: RESULTS FROM A RETROSPECTIVE MULTICENTRE STUDY 214
A novel cell line and xenograft model of ampulla of Vater adenocarcinoma 213
A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia 213
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 211
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients. 211
A preliminary experience with the HyperCHiDAM Verona intensive chemotherapy regimen in heavily pretreated refractory Hodgkin's lymphoma 208
A novel large-sized BCR-ABL transcript in a case of chronic myeloid leukaemia characterised by a favourable clinical course. 208
Protein Tyrosine Phosphatase Receptor Type γ Is a Functional Tumor Suppressor Gene Specifically Downregulated in Chronic Myeloid Leukemia 206
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 206
slan+ monocytes and macrophages mediate CD20-dependent B cell lymphoma elimination via ADCC and ADCP 203
Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myeloma. 202
Down-regulation of protein tyrosine phosphatase gamma (PTPRG) in chronic myeloid leukemia (CML) 201
ANTI-MÜLLERIAN HORMONE AND ANTRAL FOLLICLE COUNT REVEAL A LATE IMPAIR- MENT OF OVARIAN RESERVE IN PATIENTS UNDERGONE LOW GONADOTOXIC REGIMENS FOR HAEMATOLOGICAL MALIGNANCIES 194
Erectile Dysfunction after Allogeneic Hematopoietic Stem Cell Transplant: Results from a Single Center Experience 193
Mature CD10+ and immature CD10- neutrophils present in G-CSF-treated donors display opposite effects on T cells 192
Neutrophil-derived cytokines: facts beyond expression 188
Chronic graft versus host disease is associated with erectile dysfunction in allogeneic hematopoietic stem cell transplant patients: a single-center experience 188
Cellular antigens and soluble molecules and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 186
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 185
Unusual case of solitary intraparenchymal brain plasmacytoma. 182
A Disseminated Mycobacterium Abscessus Infection in a Patient Affected by Pulmonary Graft versus Host Disease: Case Report with a Revision of Literature 177
Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies 176
In reply to Schäfer et al: new evidence on the role of endothelin-1 axis as a potential therapeutic target in multiple myeloma 174
CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A. 173
Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin 172
Bone marrow mesenchymal stem cells express HER-1 and are sensitive to the effect of HB-EGF 172
Synthetic PGI-2 (Iloprost) treatment in patients with resistant sclerodermic chronic GVHD (cGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation 172
Haploidentical hematopoietic stem cell transplantation in a myelofibrosis patient with primary graft failure 171
The TNF-Family Cytokine TL1A Inhibits Proliferation of Human Activated B Cells 170
Effects of sodium selenite on in vitro interactions between platelets and endothelial cells 169
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 168
Human neutrophils in the saga of cellular heterogeneity: insights and open questions. 166
Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy 166
Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 granulocytopenic patients with hematological malignancies 164
Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome 164
Clinical and experimental efficacy of gemtuzumab ozogamicin in core binding factor acute myeloid leukemia 163
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 162
Plasmacytoid dendritic cell leukemia: a rapidly evolving disease presenting with skin lesions sensitive to radiotherapy plus hyperthermia. 156
Eighty-one percent event-free survival in advanced Burkitt's lymphoma/leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol 154
EXPRESSION AND FUNCTIONAL ACTIVITY OF THE TNFR-SUPERFAMILY MEMBER DEATH RECEPTOR 3 IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS ACTIVATED BY THE BCR 152
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study 152
Ataluren improves hematopoietic and pancreatic disorders in Shwachman-Diamond syndrome patients: a compassionate program case-series 148
Utility of anti-mullerian hormone for the evaluation of fertility preservation in female patients after chemotherapy [Determinazione dell'ormone anti-mulleriano per la valutazione della riserva ovarica in pazienti dopo trattamento chemioterapico] 148
Function analysis of estrogenically regulated protein tyrosine phosphatase gamma (PTPgamma) in human breast cancer cell line MCF-7. 147
The TNF-Family Cytokine TL1A/Death Receptor 3 System Reduces Metabolic Activity in Chronic Lymphocytic Leukemia B Cells 146
Anti-Müllerian hormone and antral follicle count reveal a late impairment of ovarian reserve in patients undergoing low-gonadotoxic regimens for hematological malignancies 146
Long-term persistence of molecular response after discontinuation of interferon-alpha in two patients with chronic myeloid leukaemia 144
Efficient lysis of B-chronic lymphocytic leukemia cells by the plant-derived sesquiterpene alcohol α-bisabolol, a dual proapoptotic and antiautophagic agent 144
Uncovering two neutrophil-committed progenitors that immediately precede promyelocytes during human neutropoiesis 143
Receptor-type protein tyrosine phosphatase gamma (PTPgamma), a new identifier for myeloid dendritic cells and specialized macrophages 143
HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation 143
Correlation between clinical features and circulating levels of soluble intercellular adhesion molecule-1 in Hodgkin's disease 142
Motility analysis of pancreatic adenocarcinoma cells reveals a role for the atypical zeta isoform of protein kinase C in cancer cell movement 140
'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 140
Allogeneic stem cell transplantation in patients with mantle cell lymphoma: results from the MANTLE-FIRST study on behalf of Fondazione Italiana Linfomi 140
Antimicrobial resistance of Gram-negative bacteria isolated from blood in HSCT patients: a multinational prospective study on behalf of the EBMT-IDWP. 139
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series 138
Functional dosing of mesenchymal stromal cell-derived extracellular vesicles for the prevention of acute graft-versus-host-disease 137
High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphoma 133
Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up. 132
Relationship between Daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemia 131
THE TNF-FAMILY CYTOKINE TL1A/DEATH RECEPTOR 3 FUNCTIONAL AXIS MODULATES B- CELL CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION 131
The cross-talk between myeloid and mesenchymal stem cells of human bone marrow represents a biomarker of aging that regulates immune response and bone reabsorption 131
Predictors of anxiety and depression in hematopoietic stem cell transplant patients during protective isolation. 130
Hyperchidam Verona897 Regimen Is Effective in Treatment of Advanced Peripheral T Cell Lymphoma (PTCL): The GITIL Experience in 33 Cases 130
Monocentric Analysis of the Effectiveness and Financial Consequences of the Use of Lenograstim Versus Filgrastim for Mobilization of Peripheral Blood Progenitor Cells in Patients With Lymphoma and Myeloma Receiving Chemotherapy and Autologous Stem Cell Transplantation 129
Concomitant chronic lymphocytic leukemia and acute myeloid leukemia: evidence of simultaneous expansion of two independent clones 128
Dasatinib-induced response in a rare case of chronic lymphocytic leukaemia associated with chronic myeloid leukaemia 127
Low‑dose anti‑IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance 123
Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors 122
Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia 122
Neutrophil-derived cytokines involved in physiological and pathological angiogenesis. 122
PBX/E2A transcript positive B-lymphoblastic leukemia (B-ALL) presenting with bilateral renal and myocardial involvement: a case report. 119
Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma 119
Primary Pancreatic Lymphoma: Clinical Presentation, Diagnosis, Treatment and Outcome 118
Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators. 115
HER-1 Transactivation by monocyte and cancer cell 7-TMD receptors 115
Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia 114
Primary mediastinal large B-cell lymphoma (PML-BCL):long term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B 113
Membrane and soluble antigens and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 112
On the persistence of the primitive chronic myeloid leukaemia cell in patients in complete molecular response 111
Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications 110
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach 109
HB-EGF/HER -1 signalling in bone marrow mesenchymal stem cells: inducing cell expansion and preventing reversibly multi-lineage differentiation 108
HB-EGF/HER -1 signalling in bone marrow mesenchymal stem cells: inducing cell expansion and preventing reversibly multi-lineage differentiation 106
On the Cytokines Produced by Human Neutrophils in Tumors. 106
IMMUNE THROMBOCYTOPENIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: CASE REPORT AND BRIEF OVERVIEW OF TREATMENT STRATEGIES 104
IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells. 103
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death 103
Rituximab-CHOP or two-weekly CHOP +G-CSF in aggressive lymphoma of the ederly ? 103
SIMILAR BUT NOT THE SAME: CHROMOSOMAL ABNORMALITIES T(8;21)(Q22;Q22) AND INV(16)(P13;Q22)/T(16;16)(P13;Q22) IDENTIFY SUBTYPES OF CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA CHARACTERIZED BY DIFFERENT SURVIVAL AND PROGNOS- TIC FACTORS 102
Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897) 101
Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large cell lymphoma 99
The National Institutes of Health criteria for classification and scoring of chronic graft versus host disease: long-term follow-up of a single center series. 95
Totale 15.883
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.887
article - articoli 46.656
book - libri 0
conference - conferenze 9.795
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 436
Totale 113.774
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021436 0 0 0 0 0 110 11 57 64 6 122 66
2021/20221.052 73 300 5 78 45 20 17 55 41 116 105 197
2022/20231.957 141 197 164 363 173 495 13 126 216 12 35 22
2023/20241.267 39 89 87 98 91 179 65 315 9 50 167 78
2024/20252.832 152 142 116 464 118 102 162 123 408 163 338 544
2025/20266.106 540 848 694 1.409 2.117 498 0 0 0 0 0 0
Totale 17.762